Main Predictions Topic Discovery Antistress
🇬🇧 English 🇪🇸 Español 🇩🇪 Deutsch 🇫🇷 Français 🇵🇱 Polski 🇨🇿 Česky 🇨🇳 中文 🇰🇷 한국어

Articles by tag: regulatory-precedent

Biosimilar without Phase 3: FDA and EMA Rewrite the Rules

Biosimilar without Phase 3: FDA and EMA Rewrite the Rules

FDA and EMA approved skipping Phase 3 for Herceptin biosimilar AP063. Learn how this decision will change the biosimilar market and accelerate access to cancer therapy.